H.C. Wainwright Reiterates Buy Rating on Zymeworks (ZYME)

April 28, 2026 6:43 AM

H.C. Wainwright analyst Andrew Berens reiterated a Buy rating and $46.00 price target on Zymeworks (NASDAQ: ZYME).The analyst commented: "Yesterday ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found